News Aclarion, Inc.

Equities

ACON

US6551872012

Real-time Estimate Cboe BZX Other stock markets 03:06:33 2024-06-06 pm EDT			5-day change	1st Jan Change
0.298 ^USD	+1.53%		-5.79%	-90.84%

May. 26	Certain Warrants of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	CI
May. 26	Certain Stock Options of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Certain Warrants of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	May. 25	CI
Certain Stock Options of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	May. 25	CI
Certain Common Stock of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	May. 25	CI
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	Apr. 25	AQ
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	Mar. 04	AQ
Aclarion Announces Closing of $3.0 Million Public Offering	Feb. 27	AQ
Top Midday Decliners	Feb. 26	MT
Aclarion Announces Pricing of $3.0 Million Public Offering	Feb. 26	AQ
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	Feb. 05	AQ
Top Premarket Decliners	Feb. 02	MT
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	Jan. 26	MT
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data	Jan. 26	MT
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index	Jan. 23	MT
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	Jan. 22	AQ
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	Jan. 17	AQ
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution	Jan. 17	CI
Top Midday Gainers	Jan. 08	MT
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	Jan. 08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aclarion, Inc.

Equities

ACON

US6551872012

Summary

Filters